Search

everythinglearnresearchcommunity

for

Search:↓

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The conclusion is that a combination of noninvasive treatments and lifestyle changes can improve skin health during menopause.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Finasteride and minoxidil work best together for hair loss.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Menopause affects hair and skin; more research needed for treatment.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.